Magseed Breast Tumor Marker receives CE Mark

Endomag has announced that it has received CE Mark approval for Magseed, a minimally invasive breast marker used to accurately guide surgeons during breast cancer removal. Magseed will be distributed throughout EMEA by Sysmex, as part of a new 5-year distribution deal for the Sentimag surgical guidance platform. Magseed allows a radiologist to accurately mark the tumour site with a seed, smaller than a grain of rice, up to 30 days before surgery.

It only takes a few minutes to put it in and, once implanted, it’s set firmly in place and cannot be dislodged before surgery. The patient is free to return home and carry out normal day-to-day activities, which significantly improves the patient experience.

In the operating theatre the surgeon uses the Sentimag to accurately locate the tumour before making an incision. This frees the surgeon to select the best approach, reducing the invasiveness of the surgery and possibly providing a better cosmetic outcome. Once inside, knowing its precise location helps ensure all of the tumour is removed.

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Previous Post

Cheaper bio-ink may be used to create artificial organs

Next Post

Can electrical installations cope with smart home demands?